Please assess the completion status of the following clinical trial:

Trial Title: A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years old ≤age≤65 years of age,male.~* Hemophilia A or B patients with inhibitors.~* Peak historical inhibitor titer ≥ 5 BU and a positive inhibitor test when enrolled.~* Establish proper venous access.~* Provide signed informed consent.~Exclusion Criteria:~* Have any coagulation disorder other than hemophilia A or B.~* Treat with prophylactic treatment of coagulation factor.~* Treat with anticoagulant within 7d of the time of study drug administration.~* Have an active, ongoing bleeding for which the patient is being treated, or treatment for a bleeding was stopped within 7d of the time of study drug administration.~* Have a history of arterial and/or venous thromboembolic events.~* Have platelet count \<100,000/mL.~* Severe liver or kidney disease.~* Accept major operation or blood transfusion within 1 month of the time of screening.~* HIV antibody positive.~* Have a known allergy to Blood product.~* Participate in other clinical research within 1 month of the time of study drug administration.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A single lowest dose of treatment group (Type: EXPERIMENTAL): None
- A single low dose of treatment group (Type: EXPERIMENTAL): None
- A single low-intermediate dose of treatment group (Type: EXPERIMENTAL): None
- A single intermediate dose of treatment group (Type: EXPERIMENTAL): None
- A single high dose of treatment group (Type: EXPERIMENTAL): None
- A single highest dose of treatment group (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).